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Biomaterials’ structural characteristics and the addition of osteoinductors influence the osteointegration
capacity of bone substitutes. This study aims to identify the characteristics of porous and resorbable bone
substitutes that influence new bone formation. An Internet search for studies reporting new bone formation
rates in bone defects filled with porous and resorbable substitutes was performed in duplicate using the
PubMed, Web of Science, Scielo, and University of Sa˜o Paulo Digital Library databases. Metaphyseal or calvarial
bone defects 4 to 10 mm in diameter from various animal models were selected. New bone formation rates
were collected from the histomorphometry or micro-CT data. The following variables were analyzed: animal
model, bone region, defect diameter, follow-up time after implantation, basic substitute material, osteo-
inductor addition, pore size and porosity. Of 3,266 initially identified articles, 15 articles describing 32
experimental groups met the inclusion criteria. There were no differences between the groups in the
experimental model characteristics, except for the follow-up time, which showed a very weak to moderate
correlation with the rate of new bone formation. In terms of the biomaterial and structural characteristics,
only porosity showed a significant influence on the rate of new bone formation. Higher porosity is related
to higher new bone formation rates. The influence of other characteristics could not be identified, possibly
due to the large variety of experimental models and methodologies used to estimate new bone formation rates.
We suggest the inclusion of standard control groups in future experimental studies to compare biomaterials.
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’ INTRODUCTION
The use of autografts for the treatment of bone defects has
well-known restrictions, including limited availability and
donor site morbidity (1). This fact has sparked an intense
search for bone substitutes of different compositions and
structural conformations (2). Some are already available on
the market, whereas many still await evidence attesting their
capacity for osteointegration and consequent commercial
viability.
A large number of new materials and material combina-
tions have been developed. Structural characteristics have
also been improved. The presence of pores significantly
increases the osteointegration capacity, whereas solid bio-
materials tend to form a fibrosis layer on the surface (3).
Furthermore, the presence of pores allows fluid circulation
inside the biomaterial, accelerates absorption of absorbable
biomaterials and decreases the peak temperature of cements
during setting (4,5). Most authors believe that pore size,
porosity and interconnection of pores enhances new bone
ingrowth. The ideal magnitude of these characteristics,
however, has not yet been established (5-7). Progressive
reabsorption and replacement of the biomaterial by nor-
mal bone is also considered an advantageous property
because inert substitutes affect bone remodeling and can
compromise its structure and mechanical resistance (8). The
addition of growth factors and other osteoinductive factors
seems to increase osteointegration, but conflicting data also
exist (9).
Comparing the many combinations of materials is a
demanding task, and the use of many different analysis
methods makes comparisons even more challenging. Com-
puted microtomography (micro-CT) and histomorphometry
(HMM) have frequently been used to quantify new bone
formation (NBF) in bone defects created in animal models
and inside the porous biomaterial (10).
The aim of this study was to identify the chemical and
structural characteristics that influence the capacity of new
bone formation of porous and absorbable bone substitutes
implanted in animal models using a systematic review.DOI: 10.6061/clinics/2017(07)10
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A systematic review was performed to evaluate how spe-
cific characteristics of porous and absorbable bone substi-
tutes used to fill bone defects in experimental in vivo studies
affects the capacity of new bone formation using micro-CTor
HMM quantifications.
Search strategy
An electronic search was independently performed by
two researchers (MJEP and MAS) between July 2014 and
February 2015 without restrictions on the publication date.
The following databases were used: PubMed, Web of Sci-
ence, Scielo, and Theses and Dissertations of the University
of São Paulo Digital Library. Only articles written in English
or Portuguese were selected. The following search term
combinations were used: (bone substitute AND porous)
OR (bone substitute AND cancellous) OR (bone substi-
tute AND spongy) OR (bone substitute AND pore)
OR (cement AND porous) OR (cement AND cancellous)
OR (cement AND spongy) OR (cement AND pore) OR (bone
cement AND porous) OR (bone cement AND cancellous) OR
(bone cement AND spongy) OR (bone cement AND pore).
Article selection strategy
Two researchers (MJEP and MAS) independently per-
formed the article selection based on the eligibility criteria by
reading the titles, summaries or full text, according to the
search strategy (Figure 1). Consensus meetings, with the parti-
cipation of a third researcher (EEE), were utilized to resolve
conflict situations. Some articles were included from the
reference lists of the selected articles.
The experimental groups of each article that met eligibility
criteria were analyzed independently; therefore, each article
could have more than one group.
Eligibility criteria
Inclusion criteria:
1. Experimental, in vivo studies in animal models;
2. Orificial defects, 4.0 mm to 10.0 mm in diameter, pro-
duced by curettage or drilling of holes;
3. Implantation of porous and resorbable bone substitutes
in the form of premolded blocks or cement with a clear
description of the composition, porosity and pore size;
4. NBF indicated as a rate according to HMMormicro-CT data.
Exclusion criteria:
1. Clinical trials, implantation in humans or in vitro studies;
2. Insufficient description of the substitute characteristics,
methodology or results;
3. Non-porous or non-absorbable substitutes;
4. Presentation in granular form. This form was excluded
due to interference with the porosity and pore size of the
substitute.
Variables
The end point variable was the rate of new bone formation
(NBF), which was based on the histomorphometry (HMM)
or micro-CT analysis data. The remaining dependent vari-
ables were as follows: animal model, bone region of the
defect, diameter of the defect (in mm), follow-up time after
implantation (in weeks), substitute basic material (calcium
phosphate, hydroxyapatite, bioglass, etc.), osteoinductor
addition (fibroblast growth factor (FGF), BMP or bone
marrow mesenchymal stem cells (BMSCs)), maximum pore
size and porosity.
Presentation of results
The NBF rates are described as the means, maximum and
minimum values. The categorical variables and maximum
defect size were grouped and compared using the Kruskal-
Wallis test. The defect size, follow-up time and porosity were
correlated to NBR using the Spearman’s correlation coeffi-
cient. PASW software version 17 (IBM SPSS, Armonk, USA)
was used for the data analysis and the level of significance
was set as 5%.
’ RESULTS
The initial search identified 3,266 studies. Figure 1 illus-
trates the selection flow. A total of 3,143 articles were exclu-
ded because the biomaterial characteristics, experimental
Figure 1 - Search strategy.
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model, NBF measurement or article language were not
eligible. Another 108 articles were excluded due to insuffi-
cient data or incomplete description of the biomaterial,
methodology or defect characteristics. From the remaining
15 articles, 32 experimental groups with different implanted
bone substitutes were considered for the analysis (Table 1).
HMM was used more frequently than micro-CT for NBF
quantification (20 groups, 62.5%). In both analysis methods,
no significant differences were found when the NBF means
were grouped according to the animal model and bone
region (Table 2). The basic materials of the bone substitutes
could not be compared because many of the material groups
became too small due to uneven distribution of the experi-
mental groups. The addition of osteoinductors to the bone
substitute did not result in a significant increase in NBF.
In addition, the influence of the pore size on NBF could
not be detected. There was no correlation between the defect
size and NBF in the HMM analysis (r=–0.181, p=0.446)
and micro-CT analysis (r=0.103, p=0.751). NBR showed a
moderate correlation to the follow-up time in the HMM
analysis (r=0.441, p=0.052) but a weak correlation in the
micro-CT analysis (r=0.122, p=0.705). NBF was significantly
influenced by porosity (Figure 2).
’ DISCUSSSION
The search for bone substitutes is a contemporary and
relevant subject (9). The large number of studies that present
new biomaterials or the further development of known
biomaterials confirms this statement. Prior to February 2015,
3,266 studies were published describing porous and absorb-
able bone substitutes filling bone defects in experimental
animals.
A large number of materials have been developed and
tested, separately or combined, to increase the capacity of
new bone formation. This continuous and effervescent
development hinders the classification of these materials
(9). In this review, we aimed to classify these materials
according to the basic material used in the production of the
bone substitute; however, there are overlaps between groups
and many materials that are classified into the same group
are not always similar. Most of the substitutes contained
HA or other types of CPs or a combination of them as the
basic material. The accumulated experience on modulat-
ing the resorption rate and mechanical resistance of these
compounds make this an attractive combination (10,18).
The number of other materials was too small to allow a
statistical analysis.
The influence of the other chemical and structural
characteristics of the biomaterials had to be very large to
be detected in such a heterogeneous sample. For this reason,
it was not possible to identify differences in the capacity of
new bone formation by comparing the different groups of
experimental animals, the sizes and locations of bone defects,
the association with osteoinducers and the pore sizes. The
follow-up time presented a weak to moderate correlation to
NBF, depending on the analysis method (HMM or micro-
CT). However, the porosity presented significant differences,
suggesting that this parameter has a strong impact on the
NBF rate.
Table 1 - Characteristics of the experimental groups.
















Del Real et al. (11) Goat Metaphysis 6.3 10 CP - 100 47.0 HMM 0.0
Del Real et al., 2002 Goat Metaphysis 6.3 10 CP - 100 59.0 HMM 20.0
Hing et al. (12) Rabbit Metaphysis 4.5 26 HA - 350 60.0 HMM 28.0
Hasegawa et al. (13) Rabbit Metaphysis 6.0 26 HA - 480 70.0 HMM 27.0
Hasegawa et al. (13) Rabbit Metaphysis 6.0 26 HA - 200 70.0 HMM 23.0
von Doernberg et al. (14) Goat Metaphysis 8.0 24 CP - 150 75.0 HMM 22.0
von Doernberg et al. (14) Goat Metaphysis 8.0 24 CP - 260 75.0 HMM 37.0
von Doernberg et al. (14) Goat Metaphysis 8.0 24 CP - 510 75.0 HMM 25.0
von Doernberg et al. (14) Goat Metaphysis 8.0 24 CP - 1220 75.0 HMM 20.0
Kroese-Deutman et al. (15) Rabbit Calvaria 6.0 12 CP - 150 71.0 HMM 17.0
Kroese-Deutman et al. (15) Rabbit Calvaria 9.0 12 CP - 150 74.0 HMM 18.0
Xu et al. (16) Rabbit Calvaria 10.0 16 CS - 400 74.9 HMM 28.4
Xu et al. (16) Rabbit Calvaria 10.0 16 CP - 400 72.3 HMM 18.8
Tang et al. (3) Rabbit Metaphysis 5.5 16 HA - 394 36.0 HMM 32.2
Keiichi et al. (17) Rat Metaphysis 4.3 12 HA - 500 52.0 Micro-CT 20.4
Keiichi et al. (17) Rat Metaphysis 4.3 12 HA FGF 500 52.0 Micro-CT 28.7
Keiichi et al. (17) Rat Metaphysis 4.3 12 HA FGF 500 52.0 Micro-CT 28.5
Calvo-Guirado et al. (18) Rabbit Metaphysis 6.0 8 HA+CP - 450 95.0 HMM 60.0
Okanoue et al. (19) Rabbit Metaphysis 5.0 12 HA - 300 85.0 Micro-CT 43.0
Okanoue et al. (19) Rabbit Metaphysis 5.0 12 CP - 400 75.0 Micro-CT 15.6
Su et al. (20) Rabbit Metaphysis 5.0 12 Bioglass - 500 76.0 Micro-CT 80.0
Su et al. (20) Rabbit Metaphysis 5.0 12 Bioglass - 500 76.0 Micro-CT 48.0
Zhao et al. (21) Rat Calvaria 5.0 8 HA BMP-2 450 75.0 Micro-CT 43.0
Zhao et al. (21) Rat Calvaria 5.0 8 HA BMP-2 450 75.0 Micro-CT 27.0
Zhao et al. (21) Rat Calvaria 5.0 8 HA - 450 75.0 Micro-CT 10.0
Klijn et al. (22) Rat Calvaria 6.0 12 CP - 500 53.2 HMM 10.8
Klijn et al. (22) Rat Calvaria 6.0 12 CP - 500 44.5 HMM 7.0
Klijn et al. (22) Rat Calvaria 6.0 12 CP - 500 42.0 HMM 6.8
Liu et al. (23) Rat Calvaria 4.6 24 Bioglass - 150 50.0 HMM 24.0
Liu et al. (23) Rat Calvaria 4.6 24 Bioglass - 500 80.0 HMM 36.0
Tayton et al. (24) Goat Metaphysis 8.0 13 HA BMSCs 192 63.4 Micro-CT 38.1
Tayton et al. (24) Goat Metaphysis 8.0 13 HA - 192 63.4 Micro-CT 24.8
NBF, new bone formation; HA, hydroxyapatite; CP, calcium phosphate; CS, calcium silicate; FGF, fibroblast growth factor; BMP-2, bone morphogenetic
protein-2; BMSC, bone marrow mesenchymal stem cells; HMM, histomorphometry.
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Despite the large number, few studies could be included
due to the significant variation in the presentation of the
bone substitutes and experimental models. In addition, the
NBF assessment method varied greatly, making comparison
unsuitable. In this review, we used the two most cited
methods, which, according to some articles, do not present
comparable values but are related (10,25,26). Therefore, the
HMM and micro-CT results were analyzed separately.
Although a substantial effort has been made by the scien-
tific community in recent years to improve bone substitutes,
some skepticism still exists regarding the effectiveness of
the currently available biomaterials to cure critical size bone
defects (27). The wide variety and geometrical shapes of
bone materials indicates that many questions remain to be
answered. More research is necessary to better understand
how NBF can be increased.
This review demonstrates that the lack of standardization
of NBF analyses has hampered the comparison of the various
types of porous and absorbable bone substitutes. Even when
limiting the evaluation to two types of quantitative anal-
yses for NBF, it was not possible to obtain accurate results.
A better description of the analyzed region of interest (ROI)
by each method could offer more precise data interpretation,
and consequently, a more consistent comparison with other
Table 2 - Median, minimum and maximum values for NBF rates and the experimental group counts according to the experimental
model and biomaterial characteristics.
HMM Micro-CT
NBF Count p-value NBF Count p-value
Animal
Rat 16.92 (6.80-36.00) 5 0.377 26.27 (10.00-43.00) 6 0.340
Goat 20.67 (0.00-37.00) 6 31.45 (24.80-38.10) 2
Rabbit 28.04 (17.00-60.00) 9 46.65 (15.60-80.00) 4
Region
Calvaria 18.53 (6.80-36.00) 9 0.102 26.67 (10.00-43.00) 3 0.459
Metaphisis 26.75 (0.00-60.00) 11 36.34 (15.60-80.00) 9
Basic material
CP 16.87 (0.00-37.00) 12 NT 15.60 (15.60-15.60) 1 NT
HA 27.55 (23.00-32.20) 4 29.28 (10.00-43.00) 9
CS 28.36 (28.36-28.36) 1 - 0
Glass 30.00 (24.00-36.00) 2 80.00 (48.00-80.00) 2
HA+CP 60.00 (60.00-60.00) 1 - - 0
Osteoinductor
None 23.05 (0.00-60.00) 20 NT 34.54 (10.00-80.00) 7 0.626
FGF - 0 28.60 (28.50-28.70) 2
BMP-2 - 0 35.00 (27.00-43.00) 2
BMSCs - 0 38.10 (38.10-38.10) 1
Maximum pore size
o 300 mm 20.13 (0.00-37.00) 8 0.588 31.45 (24.80-38.10) 2 0.829
300 - 500 mm 25.50 (6.80-60.00) 10 34.42 (10.00-80.00) 10
4 500 mm 22.50 (20.00-25.00) 2 - -
Porosity
o 5% 11.50 (0.00-32.20) 4 0.035 - -
5% - 75% 21.50 (10.80-28.36) 10 28.10 (20.40-38.10) 5 0.016
4 75% 33.33 (20.00-60.00) 6 38.09 (10.00-80.00) 7
Total 23.05 (0.00-60.00) 20 33.93 (10.00-80.00) 12
NBF, new bone formation; HA, hydroxyapatite; CP, calcium phosphate; CS, calcium silicate; FGF, fibroblast growth factor; BMP-2, bone morphogenetic
protein-2; BMSC, bone marrow mesenchymal stem cells; HMM, histomorphometry; NT, not tested. P-values from Kruskal –Wallis test.
Figure 2 - Boxplot of the NBR rates of the different porosity groups according to the analysis method (HMM or micro-CT).
NBF, new bone formation; HMM, histomorphometry. p-values from Kruskal–Wallis test.
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similar studies. Additionally, the inclusion of standard con-
trol groups with autografts or a commonly used substitute
would allow the calibration of the results and the compar-
ison of many different study groups.
We conclude that porosity has a high impact on NBF rates
and that the current lack of standardized analysis methods
and the broad variety of experimental models makes iden-
tifying the chemical and structural characteristics that pro-
vide a greater capacity for NBF almost impossible. We
suggest that standard control groups should always be used
to allow for a better comparison of the results.
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